v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2024 $ 460 [1] $ 33,232,704 [1] $ (52,618,948) $ (19,385,784)
Balance, shares at Dec. 31, 2024 [1] 4,773,628      
Net loss [1] [1] (3,809,700) (3,809,700)
Stock based compensation (Note 5) [1] 2,954,279 [1] 2,954,279
Transfer from early exercised stock option liability on vesting 1 [1] 360 [1] 361
Issuance of common stock [1] 16,414 [1] 16,414
Issuance of common stock, shares [1] 398      
Issuance of common stock and warrants from January 2025 public offering, net of offering costs $ 48 [1] 4,591,021 [1] 4,591,069
Issuance of common stock and warrants from January 2025 public offering, net of offering costs, shares [1] 479,200      
Issuance of common stock for settlement of RSU $ 6 [1] (6) [1]
Issuance of common stock for settlement of RSU, shares [1] 57,071      
Issuance of common stock upon warrant inducement, net of offering costs $ 48 [1] 2,798,151 [1] 2,798,199
Issuance of common stock upon warrant inducement, net of offering costs, shares [1] 479,200      
Repurchase of unvested early exercised common stock [1] [1]
Repurchase of unvested early exercised common stock, shares [1] (24,449)      
Balance at Mar. 31, 2025 $ 563 [1] 43,592,923 [1] (56,428,648) (12,835,162)
Balance, shares at Mar. 31, 2025 [1] 5,765,048      
Balance at Dec. 31, 2024 $ 460 [1] 33,232,704 [1] (52,618,948) (19,385,784)
Balance, shares at Dec. 31, 2024 [1] 4,773,628      
Net loss       (3,809,700)
Balance at Dec. 31, 2025 $ 975 62,527,926 (68,342,584) (5,813,683)
Balance, shares at Dec. 31, 2025 [1] 9,869,558      
Net loss (5,234,692) (5,234,692)
Stock based compensation (Note 5) 1,510,259 1,510,259
Transfer from early exercised stock option liability on vesting 313 313
Issuance of common stock $ 3 97,103 97,106
Issuance of common stock, shares [1] 29,067      
Issuance of common stock for settlement of RSU $ 7 (7)
Issuance of common stock for settlement of RSU, shares [1] 67,848      
Issuance of common stock for settlement of accrued liability 1,573,032 1,573,032
Balance at Mar. 31, 2026 $ 985 $ 65,708,626 $ (73,577,276) $ (7,867,665)
Balance, shares at Mar. 31, 2026 [1] 9,966,473      
[1] Amounts have been adjusted to reflect the 1-for-10 reverse stock split that became effective on September 8, 2025. See Note 2 “Basis of presentation and summary of significant accounting policies” for additional details.